2011
DOI: 10.1016/j.jpba.2011.01.040
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous determination of alfentanil and midazolam in human plasma using liquid chromatography and tandem mass spectrometry

Abstract: A fast, sensitive and selective liquid chromatography–tandem mass spectrometry (LCMS/MS) method for the determination of alfentanil and midazolam in human plasma has been developed and validated. Alfentanil and midazolam were extracted from plasma using a mixed-mode cation exchange solid phase extraction method, with recoveries of both compounds greater than 80% at 3 different concentrations (1, 10 and 100 ng/ml). Compounds were analyzed on a C18 column with a water and methanol mobile phase gradient with acet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…Analytical methods . Plasma MDZ and ALF concentrations were measured by high‐performance liquid chromatograph tandem mass spectrometry with multiple reaction monitoring as previously reported 48 . Interday coefficients of variation were 7, 8, and 7% at 1.4, 12, and 100 ng/ml MDZ, and 9, 7, and 7% at 1, 10, and 100 ng/ml ALF, respectively.…”
Section: Methodsmentioning
confidence: 97%
“…Analytical methods . Plasma MDZ and ALF concentrations were measured by high‐performance liquid chromatograph tandem mass spectrometry with multiple reaction monitoring as previously reported 48 . Interday coefficients of variation were 7, 8, and 7% at 1.4, 12, and 100 ng/ml MDZ, and 9, 7, and 7% at 1, 10, and 100 ng/ml ALF, respectively.…”
Section: Methodsmentioning
confidence: 97%
“…HPLC with UV/Vis detection has been used for MDZ determination with an LOD in the range of 0.2–22.7 ng/mL and plasma requirement per assay in the range of 0.2–2 mL . The LOD can be reduced by an order of magnitude (∼0.01 ng/mL) by using HPLC with MS detection or GC with MS detection , using about the same plasma volume per assay (0.1–1.0 mL). GC with electron capture detector (ECD) or nitrogen phosphorus detection (NPD) made it possible to attain an LOD in the range 0.5–3 ng/mL, using plasma volumes of about 1 mL per assay, which are comparable with those used for HPLC–UV/Vis.…”
Section: Introductionmentioning
confidence: 99%